Shingen Misaka, Osamu Abe, Tomoyuki Ono, Yuko Ono, Hiroshi Ogata, Itaru Miura, Yayoi Shikama, Martin F Fromm, Hirooki Yabe, Kenju Shimomura
Journal: British journal of clinical pharmacology 2021;86(11):2314-2318
PMID: 32320490
AIMS
The aim of this study was to investigate the effects of a single green tea (GT), administered concomitantly or 1 hour before nadolol intake on nadolol pharmacokinetics.
METHODS
In a randomized 3-phase crossover study, 11 healthy volunteers received an oral administration of nadolol with, or 1 hour after preingestion of brewed GT, or with water in a volume of 150 mL.
RESULTS
Geometric mean ratio with 90% confidence interval for nadolol AUC was 0.371 (0.303-0.439) with concomitant GT. In addition, ingestion of GT 1 hour before nadolol administration resulted in a significant reduction of nadolol AUC with geometric mean ratio of 0.536 (0.406-0.665). There were no differences in time to maximal plasma concentration and renal clearance of nadolol among groups.
CONCLUSION
These results suggest that single concomitant ingestion of GT substantially decreases plasma concentrations of nadolol. Moreover, the reduction in nadolol bioavailability could persist for at least 1 hour after drinking a cup of GT.
© 2020 The British Pharmacological Society.
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.